CLU
0.015
150%
HYT
0.006
-57.1%
WNX
0.115
105.4%
TKM
0.058
-47.3%
ITM
0.053
71%
LML
0.007
-46.2%
AU1
0.034
54.5%
LKO
0.265
-37.6%
MRQ
0.003
50%
ATC
0.002
-33.3%
QEM
0.022
46.7%
OVT
0.002
-33.3%
AQZ
0.83
41.9%
TMX
0.002
-33.3%
ALB
0.056
40%
ARO
0.003
-25%
NFM
0.007
40%
NES
0.003
-25%
SLD
0.6
39.5%
ALU
0.67
-23.9%
SNT
0.035
34.6%
BTN
0.012
-20%
ABE
0.02
33.3%
ENL
0.004
-20%
HIQ
0.008
33.3%
FIN
0.004
-20%
MHM
0.16
33.3%
MAY
0.004
-20%
SMM
0.012
33.3%
PCL
0.008
-20%
WC1
0.016
33.3%
IBR
0.056
-18.8%
FAL
0.55
32.5%
BPG
0.295
-18.1%
MYE
0.53
32.5%
AGE
0.044
-17%
PPK
0.45
32.4%
CD2
0.3
-16.7%
AHK
0.315
31.3%
ZEU
0.005
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Interviews

Acrux (ASX:ACR) is continuing to advance its Female Testosterone programme, with the FDA providing a clear pathway toward late-stage clinical trials and global pharmaceutical companies showing strong interest in partnering on its product. Alongside this, the company's commercial business continues to generate cash, helping fund development of what management describes as a once-in-a-generation opportunity in women's health. CEO & Managing Director John Warmbrunn joins The Stock Network's Lel Smits to discuss the June quarter, the Female Testosterone opportunity, growing commercial momentum and the key milestones ahead. 1. Female Testosterone progress and US FDA The FDA has provided greater clarity on the next steps for Female Testosterone, while interest from potential partners continues to build. Why is this such an important milestone, and what does it mean for the future of the programme? 2. A major opportunity in women's health Millions of women have limited treatment options for low libido, making this a significant unmet medical need. What makes Female Testosterone different, and why do you believe it has the potential to make a real impact? 3. Commercial catalysts With Phase III planning underway, partnership discussions progressing and additional Lenzetto® milestones available, what are the commercial catalysts we should be watching for? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Acrux (ASX:ACR): Advances Female Testosterone “once in a generation opportunity”
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5CMDU4Mjk2QjA2QTIwODZB

Acrux (ASX:ACR): Advances Female Testosterone “once in a generation opportunity”

EBR Systems (ASX:EBR) is advancing cardiac resynchronisation therapy with the world's only leadless pacing technology designed for heart failure patients. The company's WiSE™ CRT System delivers wireless pacing directly inside the heart, offering an alternative to conventional systems that rely on pacing leads. As EBR expands commercial adoption of WiSE™ the company continues to refine the physician experience with procedural innovations, including the optional Coupler accessory developed to support electrode implantation. Dr Anne Kroman, DO, PhD, Director of Electrophysiology Lab and Cardiac Device program at the Medical University of South Carolina, joins The Stock Network's Lel Smits to discuss where the Coupler fits within the WiSE implant procedure, its role during electrode implantation, and how procedural tools can support physician confidence as more centres adopt the technology. 1. Where the Coupler fits within the WiSE implant procedure From a physician's perspective, where does the Coupler fit within the WiSE implant workflow, and what role does it play during electrode implantation? 2. Supporting stability, control and electrode advancement Why are stability, control and slow, steady electrode advancement so important during this stage of the procedure, and how does the Coupler help support that process? 3. Supporting consistency as WiSE adoption expands As more physicians and centres begin performing WiSE procedures, how can procedural tools such as the Coupler help support consistency, physician confidence and broader adoption? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
EBR Systems (ASX:EBR): Physician perspective on the Coupler supporting WiSE procedures
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS45NkM5QURGMTI1Rjg4NDRC

EBR Systems (ASX:EBR): Physician perspective on the Coupler supporting WiSE procedures

Teaminvest Private Group (ASX:TIP) owns the Teaminvest investing platform, bringing together a community of self-directed investors to move beyond speculation by applying a disciplined, long-term investment frameworks. Teaminvest investors collectively deploy more than $3 billion into equities by identifying high-quality businesses capable of compounding earnings over many years. Head of Funds Management and Education, Sanjee Narendran, joins Lel Smits from The Stock Network to discuss the principles behind successful long-term investing, how experienced investors separate quality from hype, and why a proven framework can deliver more consistent investment outcomes through all market cycles. 1. Why most investors underperform despite doing the research Many investors spend countless hours researching companies, yet still struggle to consistently outperform the market. What are the biggest mistakes self-directed investors make and how can they avoid them? 2. How to identify long-term Wealth Winners® Teaminvest focuses on identifying businesses with sustainable earnings growth, competitive advantages and high-quality management teams rather than chasing market trends. What characteristics define what you describe as a true long-term Wealth Winner®? 3. Investing through market volatility Periods of market uncertainty often cause investors to abandon long-term strategies in favour of emotional decision-making. How does Teaminvest encourage members to remain disciplined during market downturns? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Teaminvest Private Group (ASX:TIP): How investors are identifying long-term wealth winners
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5DMTA0RkI2RTNGNUQ0Njgw

Teaminvest Private Group (ASX:TIP): How investors are identifying long-term wealth winners

As ETFs continue to grow in popularity, investors are increasingly comparing active and passive strategies to understand which approach may best suit their investment goals. In this Women in ETF’s Education Spotlight, The Stock Network’s Lel Smits is joined by Kanish Chugh, Head of ETF Sales at PIMCO Australia, to discuss the key differences between active and passive ETFs, how each strategy works, and what investors should consider when building portfolios. 1. Understanding active vs passive ETFs Can you explain the core differences between active and passive ETFs and how each strategy works? 2. Benefits of passive investing Why have passive ETFs become so popular globally and what are some of their key advantages for investors? 3. The role of active ETFs What are active ETFs designed to achieve and in what market environments can active management become particularly valuable? 4. Choosing between active and passive How should investors think about deciding between active and passive ETFs when constructing a portfolio? 5. Common misconceptions What are some of the biggest misunderstandings investors have about active versus passive investing? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
ETF Education Spotlight: Active vs Passive ETFs: What’s the Difference?
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS45REM1NzQ1MDM2OUZDNDMx

ETF Education Spotlight: Active vs Passive ETFs: What’s the Difference?

SCX.ai Holdings (ASX:SCX) is seeking to become one of the ASX's newest pure-play artificial intelligence companies through a proposed $40 million IPO, positioning itself as Australia's sovereign AI infrastructure and services platform. Focused on providing Australian enterprises and government agencies with secure, locally hosted AI infrastructure, inference services and managed AI solutions, the company is targeting growing demand for sovereign AI capabilities as organisations prioritise data privacy, regulatory compliance and domestic AI infrastructure. SCX.ai CEO David Keane, founder of ASX success story Bigtincan (ASX:BTH), joins The Stock Network's Lel Smits to discuss the company's proposed ASX listing, Australia's sovereign AI opportunity, enterprise demand for locally hosted AI, and how SCX.ai plans to build a leading domestic AI platform. 1. Australia's sovereign AI opportunity As artificial intelligence adoption accelerates globally, organisations are becoming increasingly focused on where their data is stored and processed. Why is sovereign AI becoming such an important theme? 2. Preparing for an ASX listing SCX.ai is seeking to raise $40 million through its proposed ASX IPO. What will this capital enable the business to achieve? 3. Building Australia's AI infrastructure SCX.ai offers a vertically integrated platform spanning AI infrastructure, inference services and managed AI applications. How does this integrated model differentiate the company? 4. Scaling enterprise adoption With growing demand from regulated industries including financial services, healthcare and government, what are the key growth drivers over the next few years? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
SCX.ai Holdings (ASX:SCX): Australia's sovereign AI platform preparing for ASX debut
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5FRDc0QkQxMzlEMTZBMzg0

SCX.ai Holdings (ASX:SCX): Australia's sovereign AI platform preparing for ASX debut

EchoIQ (ASX:EIQ) has delivered a share price gain of more than 500% over the past year as investors back its AI-powered decision support technology for structural heart disease. With FDA-cleared, clinically validated solutions that use existing echocardiographic measurements to provide rapid clinical insights without image analysis, EchoIQ is building a differentiated position in cardiovascular diagnostics. EchoIQ's CEO Dustin Haines joins The Stock Network's Lel Smits to discuss its research collaboration with Mayo Clinic, binding Heads of Agreement with Pro Medicus (ASX:PME), a $110 million institutional placement and access to an exclusive imaging dataset designed to further strengthen its AI competitive moat. 1. Mayo Clinic collaboration: Validating the technology Securing a research collaboration with Mayo Clinic is a major endorsement given its global reputation in cardiovascular medicine. What opportunities could this unlock for EchoIQ, and how important is world-leading clinical validation for accelerating commercial adoption? 2. Pro Medicus partnership: Unlocking distribution EchoIQ recently secured a binding Heads of Agreement with Pro Medicus, one of Australia's most successful global healthcare technology companies. How transformational could this relationship become, and what does it potentially mean for expanding access to hospitals and clinicians worldwide? 3. A$110 million raise: Funding the next growth phase Following a gain of more than 500% in your share price over the last year, EchoIQ raised $110 million. What does this capital allow EchoIQ to achieve over the next few years, and what milestones should investors be watching? 4. Building an AI competitive moat EchoIQ has strengthened its competitive position through an exclusive imaging dataset, providing access to one of the largest collections of echocardiographic data available. How significant is this data advantage in developing future AI products, and where do you see EchoIQ's next wave of growth coming from? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
EchoIQ (ASX:EIQ): AI-powered heart diagnostics targeting global healthcare scale
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS44MjZDNDYzQjgwQzkzQzkz

EchoIQ (ASX:EIQ): AI-powered heart diagnostics targeting global healthcare scale

Epiminder (ASX:EPI) is a medical device company developing the FDA-approved Minder® System, a breakthrough subscalp EEG monitoring technology designed to improve the diagnosis and management of epilepsy. The Company has now achieved its 50th patient enrolment in the landmark DETECT clinical trial ahead of schedule, with 20 leading US epilepsy centres, including Mayo Clinic, Harvard, Stanford, Yale, Duke and the University of Pennsylvania, actively recruiting patients as the study builds momentum toward its target of 210 participants. Epiminder CEO Rohan Hoare joins The Stock Network's Lel Smits to discuss why accelerating enrolment in DETECT is an important validation of the Minder System and what it could mean for the Company's commercial opportunity. 1. Clinical momentum and the unmet need DETECT has reached 50 patient enrolments ahead of schedule, with some of the world's leading epilepsy centres now actively participating. What does this momentum tell you about clinician confidence in the Minder System, and why is there such a significant unmet need for better epilepsy monitoring? 2. The path to commercial adoption As DETECT progresses toward its target of 210 patients, what are the key milestones investors should be watching, and how could positive clinical data help drive broader adoption of the Minder System in the US healthcare market? 3. Why leading US hospitals are backing DETECT The study now includes world-renowned institutions including Mayo Clinic, Stanford and Yale. What does the calibre of these participating centres say about the potential of the Minder System and the significance of the DETECT trial? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Epiminder (ASX:EPI): Accelerating clinical momentum as landmark US epilepsy study grows
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5FRjZBRjlFMTZFQkZCNzE5

Epiminder (ASX:EPI): Accelerating clinical momentum as landmark US epilepsy study grows

As ETFs continue to grow in popularity among Australian investors, much of the focus is placed on performance, fees and investment strategy. However, behind every ETF is a network of specialist service providers that help ensure investors can buy, sell and hold ETF units efficiently. One of these important functions is ETF registry services, which support investor records, corporate actions, distributions and the broader administration of ETF products. In this ETF Education Spotlight with Women in ETFs, The Stock Network's Lel Smits is joined by Rakitha Amaranath, Head of ETP Services at MUFG Corporate Markets. MUFG Corporate Markets is the biggest ETF registry provider in Australia, holding around 50% of the market. Rakitha will discuss the role of ETF registries, how they fit into the ETF ecosystem, and why understanding the infrastructure behind ETFs can help investors become more informed market participants. 1. Understanding the ETF ecosystem When investors buy an ETF, they often focus on the fund manager and the underlying investments. Can you walk us through the broader ETF ecosystem and where registry services fit within that structure? 2. The role of an ETF registry What does an ETF registry actually do, and what are some of the key functions investors may interact with without even realising it? 3. Supporting investor experience From distributions and tax reporting through to investor communications and corporate actions, how does the registry help ensure ETF investors receive accurate information and services? 4. ETF growth and operational complexity The Australian ETF market has grown rapidly over the past decade. How has that growth changed the demands placed on registry providers, and what trends are you seeing across the industry? 5. Innovation and the future of ETF servicing As ETFs continue to evolve, including active ETFs, thematic products and new investment structures, how is the registry function adapting to support the next phase of industry growth? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
ETF Education Spotlight: Behind the scenes of ETFs, understanding ETF registry and market structure
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5DM0UwMkNDRTIwQUNDMjE2

ETF Education Spotlight: Behind the scenes of ETFs, understanding ETF registry and market structure

Elsight (ASX:ELS) is building the technology that helps drones and autonomous systems stay reliably connected in demanding environments. As adoption accelerates across defence, public safety and commercial industries, Elsight is expanding its product portfolio beyond connectivity while strengthening its presence in the key U.S. market. CEO Yoav Amitai joins The Stock Network's Lel Smits to discuss record revenue, growing commercial adoption and the rollout of new AI-powered technology. 1. Powering the future of connected drones Elsight's technology is designed to keep drones connected when reliability is critical. For investors new to the story, what problem does Elsight solve, and why is demand growing across both defence and commercial markets? 2. Expanding beyond connectivity with AI and new products Elsight is now introducing AI-powered positioning technology and expanding its product portfolio beyond connectivity. How do these new products strengthen Elsight's competitive advantage, and what opportunities do they open up over the longer term? 3. Building momentum in the U.S. You've continued to win repeat customers, deepen relationships in the U.S. and expand into new applications such as public safety. What are your immediate priorities for Elsight and your outlook over the coming year? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Elsight (ASX:ELS): Expanding global drone connectivity with AI, defence momentum & commercial growth
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS41MUY0NzFFRjMwMkI3RTI1

Elsight (ASX:ELS): Expanding global drone connectivity with AI, defence momentum & commercial growth

View More

Get the latest ASX stock market news delivered to your inbox

By proceeding, you can confirm you understand that we handle personal informational in accordance with our Privacy Policy